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Topologically associated domains (TADs)
A B S T R A C T
Keratolenticular dysgenesis (KLD) and ectopia lentis are congenital eye defects. The aim of this study is the
identification of molecular genetic alterations responsible for those ocular anomalies with neurologic impair-
ment in an individual with a de novo balanced chromosome translocation t(11;18)(q23.3;q11.2)dn. Disruption of
OAF, the human orthologue of the Drosophila oaf, by the 11q23.3 breakpoint results in reduced expression of this
transcriptional regulator. Furthermore, four most likely nonfunctional chimeric transcripts comprising up to OAF
exon 3, derived from the der(11) allele, have also been identified. This locus has been implicated by publicly
available genome-wide association data in corneal disease and corneal topography. The expression of the po-
liovirus receptor-related 1(PVRL1) or nectin cell adhesion molecule 1 (NECTIN1), a paralogue of nectin cell
adhesion molecule 3 (PVRL3) associated with congenital ocular defects, situated 500 kb upstream from 11q23.3
breakpoint, is increased. The 18q11.2 breakpoint is localized between cutaneous T-cell lymphoma-associated
antigen 1(CTAGE1) and retinoblastoma binding protein 8 (RBBP8) genes. Genomic imbalance that could con-
tribute to the observed phenotype was excluded. Analysis of gene expression datasets throughout normal murine
ocular lens embryogenesis suggests that OAF expression is significantly enriched in the lens from early stages of
development through adulthood, whereas PVRL1 is lens-enriched until E12.5 and then down-regulated. This
contrasts with the observation that the proposita's lymphoblastoid cell lines exhibit low OAF and high PVRL1
expression as compared to control, which offers further support that the alterations described above are most
likely responsible for the clinical phenotype. Finally, gene interaction topology data for PVRL1 also agree with
our proposal that disruption of OAF by the translocation breakpoint and misregulation of PVRL1 due to a po-
sition effect contribute to the observed ocular and neurological phenotype.
1. Introduction
Kerato-irido-lenticular dysgenesis (KILD) is a genetically and phe-
notypically heterogeneous congenital malformation of the anterior
chamber of the eye. This condition, traditionally known as Peters
anomaly (PA; OMIM #604229), generally leads to severe visual im-
pairment. PA or KILD is characterized by central corneal opacity or
leucoma, adhesion between the central anterior surface of the lens and
posterior surface of the cornea with or without iridocorneal adhesions
(Nischal, 2015).
Most PA cases are of recessive inheritance and sporadic occurrence,
but autosomal dominant inheritance is also reported (David et al.,
2003). The prevalence of PA remains unknown and recently the in-
cidence in United States was estimated to be 1.1 to 1.5 per 100,000 live
births (Kurilec and Zaidman, 2014). In about two-thirds of cases PA is
isolated, and in about 50% it is unilateral (Ozeki et al., 2000).
PA has repeatedly been reported in association with a variety of
other ocular malformations (Ozeki et al., 2000). Indeed, genes causing
aniridia (OMIM #607108, PAX6 on 11p13), isolated or syndromic
forms of Axenfeld-Rieger syndromes (OMIM #180500 and 602482,
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PITX2 on 4q25, and FOXC1 on 6p25.3), and primary congenital glau-
coma (PCG, OMIM #231300, CYP1B1 on 2p22.2), have been observed
in association with PA. In addition to these four genes,MAF, FOXE3 and
PITX3 have also been occasionally reported to be involved in PA
(Jamieson et al., 2002; Doucette et al., 2011; Summers et al., 2008).
Recently, exome sequencing data suggested possible involvement of
TFAP2A, HCCS, NDP, FLNA and SLC4A11 in the etiology of PA (Weh
et al., 2014). Hence, no specific PA-causing gene has been identified so
far. In addition to the well-defined Peters-plus syndrome (OMIM
#261540, B3GALTL on 13q12.3) other congenital malformations have
been reported in association with PA (Ozeki et al., 2000; Mwenda,
2012).
Congenital ectopia lentis (EL) is a rare ocular anomaly characterized
by dislocation or malposition of the ocular lens (Chandra and Charteris,
2014). This condition occurs predominantly as a manifestation of sys-
temic diseases such as Marfan syndrome (MFS, OMIM #154700, FBN1
on 15q21). Unilateral EL is often related to trauma or other ocular
disorders.
Anterior segment dysgenesis (ASD) disorders including PA have
been reported, from time to time, associated with chromosomal ab-
normalities including reciprocal chromosome translocations (RCT)
(David et al., 2003). Indeed, several genes responsible for the genetic
etiology of ASD disorders have been identified through breakpoint
mapping of chromosomal rearrangements (Mataftsi et al., 2011). This
approach continues to be important in the identification of novel genes
involved in human developmental disorders (Redin et al., 2017). In
fact, by using this approach, in 2003 we identified TGFB2 as a most
likely PA-causing gene (David et al., 2003).
In the present study, we describe a de novo balanced RCT [t(11;18)
(q23.3;q11.2)dn] in a subject with KLD (or type 2 PA) in the right eye,
ectopia lentis in the left eye, and neurological impairment. Identification
of the breakpoints at nucleotide resolution, comprehensive molecular
analysis of the flanking genomic regions, and potential candidate gene
search in the light of chromatin topologically associated domains
(TADs), reinforced by gene expression data during normal murine
ocular lens embryogenesis lead us to conclude that disruption of OAF by
the translocation breakpoint and developmental misregulation of
PVRL1, are the main molecular alterations most likely responsible for
the phenotype observed in this subject.
2. Materials and methods
2.1. Samples, lymphoblastoid cell lines (LCLs), chromosome painting and
fluorescence in-situ hybridization (FISH) mapping
Blood samples from the proposita and her relatives were collected
after informed consent. The study was carried out according to the
Principles of the Declaration of Helsinki of the World Medical
Association. Establishment of LCLs from peripheral blood lymphocytes,
whole chromosome painting (WCP) and FISH mapping, were performed
as previously described (David et al., 2003, 2013).
2.2. DNA extraction, flow sorting of derivative (der) chromosomes, genomic
amplification, array painting and genomic array analysis
Genomic DNA extraction from peripheral blood lymphocytes and
LCLs, flow sorting and amplification of DNAs from der(11) and der(18)
chromosomes were performed as described (David et al., 2013).
Total genomic DNA from the proposita and the genomic amplicon of
der(11) were analyzed using high-resolution CytoScan HD genomic
array from Affymetrix (Santa Clara, CA, USA), performed according to
the manufacturer's instructions. Array data were analyzed using the
chromosome analysis suite (ChAS) software and NetAffy Genomic
Annotation file version 33.1 hg19, from Affymetrix. Potential alterations
or CNVs were queried in the Database of Genomic Variants (DGV;
http://dgv.tcag.ca/dgv/app/home).
2.3. Amplification of the junction fragments and mutation screening of
CYP1B1
Amplification conditions for the der(11) and der(18) junction
fragments, with primer pairs OAF-5F/AC110583-7R and AC110583-
8F/AP000679-2R, respectively are summarized in Supplementary Table
S1. The resulting junction fragments were sequenced by the Sanger
method (David et al., 2013). For details regarding mutation screening
of CYP1B1 see Supplementary material.
2.4. RNA extractions and expression studies
Extraction of RNA from LCLs and peripheral blood of the proposita,
family members and controls as well as quality assessment and quan-
tification of RNAs were performed as described earlier (David et al.,
2013).
Genome-wide assessment of gene expression levels in LCL of the
proposita and controls were performed using the Human Gene 1.0 ST
expression array from Affymetrix according to the manufacturer's in-
structions. Data from eight unrelated LCL samples were used as controls
and the analysis was performed using the Chipster v3.6 open source
platform (http://chipster.csc.fi/). For additional details, see
Supplementary material.
Expression levels of several genes mapping to the breakpoint re-
gions were analyzed by TaqMan gene expression assays. The informa-
tion regarding these genes, assays, amplicons, amplification conditions
and relative quantification of target genes are available in
Supplementary material and Table S2.
Transcripts from reference genomic regions, equivalent to the
breakpoint-spanning and flanking TADs from each breakpoint, were
enriched using capture probe libraries. The probes were designed by
Roche-Nimblegen using Custom SeqCap EZ design for hg19 regions
covering the reference TADs (Supplementary Table S3). Regions cov-
ering TAD boundaries, VISTA enhancers, candidate genes and break-
points were more densely tiled. Probes were allowed up to 20 close
matches in the genome. Probes to capture 50 External RNA Control
Consortium (ERCC) controls were also added. Approximately 8.5% of
the selected regions were untargetable due to repeats. Of the remaining,
a median coverage of 95% was achieved. Capture was performed on
cDNA libraries prepared from 100 ng total RNA as previously described
(see Supplementary material) (Mercer et al., 2014). The average clone
size in the enriched pooled library was 345 bp. Sequencing was per-
formed using the Illumina HiSeq2500 platform and version 4 chemistry
for cluster generation, and sequenced with 150 bp paired-end sequen-
cing. RNA CaptureSeq data analysis can be found in Supplementary
material.
2.5. Meta-analysis of mouse expression array datasets
For expression analysis of mouse orthologues of the identified po-
tential human candidate genes during normal murine ocular lens em-
bryogenesis, publicly available genome-wide mouse expression array
datasets were used.
Expression and enrichment in lens tissue of mouse orthologues was
obtained by comparison of fluorescent expression intensities at em-
bryonic day (E) E10.5, E11.2, E12.5, E16.5 and E17.5, and postnatal
day (P) P0 and P56 stages to reference whole body (WB) controls, as
previously described (Agrawal et al., 2015).
Similarly, expression and enrichment in the isolated lens epithelium
at P28 for the Oaf and Pvrl1 genes was obtained by analyzing the
specific probe signal intensity. Comparative analyses of these two genes
with the whole body embryonic tissue (WB) reference dataset, ex-
pressed as fold-change differences, provided an estimate of their “en-
riched” expression in the P28 lens epithelium. For additional informa-
tion regarding the source mouse expression array datasets and analyses,
see Supplementary material.
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2.6. Topologically associated domain (TAD) data
Hi-C chromatin interaction maps from the analyzed TADs or gene
regions were generated for the human embryonic IMR90 fibroblast cell
line (ATCC CCL-186) and human LCL GM12878 with MboI digestion
from the publicly available GEO GSE63525 dataset (https://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc=GSE63525) (Rao et al., 2014).
For detailed bioinformatics analysis of Hi-C sequencing libraries,
heat maps of Hi-C chromatin interactions and Circos plot of gene in-
teraction profiles please see Supplementary material.
3. Results
3.1. Clinical and ophthalmological features
The proposita is the third child of non-consanguineous parents. Her
father has congenital nystagmus, but otherwise her parents as well as
her siblings are healthy. At birth, she was small and hypotonic and
required assisted ventilation. Her parents noticed a grey dot in the right
eye. Motor development was slower compared to her siblings. She
learned to walk properly at the age of three years. No dysmorphic
features were noted.
Ophthalmologic examination performed at four years and ten
months of age revealed microphthalmic eyes with secondary develop-
mental KLD or type 2 PA in her right eye (OD), the lens with anterior
cataract adherent to the centrally opacified cornea, and inferonasal
subluxation of the lens in her left eye (OS) (Fig. 1). In the right eye there
were some fine iris strands and vessels attached to lens epithelium but
no pupillary membrane or persistent fetal vasculature causing me-
chanical lens-cornea adhesion. Medical history shows that there was no
additional report of ASD in her family.
At six years of age, the lens and the cornea were clear in the OS with
inferonasal subluxation of the lens. The posterior segment was normal.
Visual acuity was low because of bad optics due to lens subluxation.
The OS was submitted to lens extraction with repositioning of the lens
capsule with transsclerally fixated capsular tension ring and intraocular
lens (IOL) implantation. Vision improved from 0.08 to 0.4.
At seven years of age, the axial length of the OD was 18.44mm
(normal average 22mm ± 0.61). Visual acuity before cataract opera-
tion was 0.1 (20/200 or 6/60). The cornea was clear at the periphery
but cloudy in the optic axis due to adhesions between the lens and
corneal endothelium. The lens had an anterior, pyramid-shaped opa-
cification to which some vessels grew from the inferonasal atrophic iris.
The pupil did not react properly to light. The posterior segment of the
eye (retina, optic nerve) was normal. At this age, the OD was submitted
to excision of lenticulocorneal adhesion, extracapsular cataract ex-
traction (ECCE) and IOL implantation. Visual acuity improved mar-
ginally (0.2) due to deep amblyopia.
Neurological evaluation at four and a half years revealed motor
clumsiness or coordination problems, repeatedly abnormal electro-
encephalogram (spikes in two independent foci in the occipital region)
and slightly exaggerated signals from the nucleus caudate on magnetic
resonance imaging examination. At the age of four she spoke relatively
fluently, but stuttered and she received speech and physical therapy.
3.2. Cytogenetic studies
Analysis of GTL-banded metaphase chromosomes revealed in the
proposita an apparently balanced reciprocal chromosomal translocation
between the long arms of chromosomes 11 and 18 46,XX,t(11;18)
(q25;q11.2)dn (Supplementary Figs. S1a and b). The de novo (dn)
nature of the translocation was demonstrated by the fact that the kar-
yotypes of the proposita's parents were normal.
3.3. Mapping of the breakpoints at nucleotide resolution and identification
of candidate genes
First, breakpoint-spanning BAC clones were identified
(Supplementary Figs. S1d and S2b). The 11q25 breakpoint was further
delimited by FISH mapping of long-range PCR fragments. A 7.75 kb
fragment (g.OAF4/AP11503) encompassing OAF exons 2–4 was iden-
tified as the shortest breakpoint-spanning FISH probe (Supplementary
Figs. S2c and d).
Subsequently, der-chromosomes were separated from their normal
counterparts by dual-laser flow sorting and breakpoints were more
precisely localized by array painting with the der(11) amplicon
(Supplementary Figs. S1e–g).
Primers flanking the breakpoints were designed, and junction
fragments amplified, and Sanger sequenced (Supplementary Table S1
and Fig. S3). According to the next-gen cytogenetics nomenclature, the
breakpoints can be defined as: seq[hg38] t(11;18)(11pter-
> 11q23.3(120,227,15{9}):18q11.2(22,640,75{1})- > 18qter;
(18pter-> 18q11.2(22,640,751):11q23.3(120,227,159)- > 11qter)dn
(Ordulu et al., 2014). The translocation, according to the International
System for Human Cytogenetic Nomenclature (ISCN) 2016, is defined
as seq[GRCh38] t(11;18)(11pter→11q23.3:18q11.2→ 18qter;18pter→
18q11.2:11q23.3→ 11qter)dn.
The 11q23.3 breakpoint was identified at position
g.120,227,159_120,227,160 [hg38] within IVS3 of OAF, the human
orthologue of the Drosophila “out at first” (oaf) (Supplementary Figs. S2c
and S3). Based on FANTOM CAT browser data on genome wide asso-
ciation studies (GWASs; http://fantom.gsc.riken.jp/cat/v1/#/genes/
ENSG00000184232.4) the OAF locus has been associated with cor-
neal disease, and corneal topography (rs2444239, at posi-
tion120,185,707; p= 4.500E-07 and rs494965, at position
120,182,942; p=4.00E-7).
Fig. 1. Ocular phenotype of the proposita.
A) Oculus dexter (OD) before ocular surgery; micro-
phthalmic eye with congenital keratolenticular dysgenesis
or type 2 Peters anomaly (type 2 PA). The lens presents an
anterior, pyramid-shaped opacification (white arrowhead)
to which some fine iris strands (yellow arrowhead) and
vessels grew from the inferonasal atrophic iris. The cornea
is clear at the periphery but cloudy in the optic axis due to
adhesions between the lens and corneal endothelium.
B) Oculus sinister (OS) before ocular surgery; micro-
phthalmic eye with inferonasal subluxation of the lens.
Otherwise the lens and the cornea are clear.
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Proximally, the breakpoint is flanked by a member of the tripartite
motif (TRIM) proteins family, TRIM29. About 10 kb distal from this
location lies the gene encoding POU domain, class 2 transcription factor
3 (POU2F3), also known as octamer-binding transcription factor 11
(OCT11). About 100 kb further distal, maps the Rho guanine nucleotide
exchange factor 12 (ARHGEF12). Additional functionally important
genes are localized within the reference IMR90 breakpoint-spanning
TAD (brTAD). Among these genes is poliovirus receptor-related 1
(PVRL1) also known as NECTIN1, a member of the Ca2+-independent
immunoglobulin-like cell adhesion molecules, localized about 500 kb
proximal to the breakpoint (see Fig. 2B). A paralogue of this cell ad-
hesion protein, PVRL3, was recently shown to have an important role in
mammalian lens and ciliary body development. Misregulation of PVRL3
expression by t(1;3)(q31.3;q13.13) translocation also leads to con-
genital ocular defects in human and its targeted deletion in mice causes
severe eye defects (Lachke et al., 2012). Mutations affecting PVRL1
have been reported to cause autosomal recessive cleft lip/palate-ecto-
dermal dysplasia syndrome (CLPED1; OMIM #225060) and a form of
orofacial cleft (OFC7) (OMIM #225060) (Suzuki et al., 2000). Inter-
action plots depict extensive interactions between OAF or the break-
point region and PVRL1 (Fig. 3).
These adhesion proteins (PVRL1 and 3) are direct interacting part-
ners, mediating apex-apex adhesion between the anterior lens epithe-
lium and fiber cells, as well as between pigmented and non-pigmented
cell layers of the ciliary body epithelium (Lachke et al., 2012). Ad-
ditionally, are also expressed in the brain at synaptic junctions and
puncta adherentia junctions (Takai et al., 2003). Both are down regu-
lated during TGFB induced epithelial-mesenchymal transition, known
to play an important role in the pathogenesis of ASD (Li et al., 2016;
http://fantom.gsc.riken.jp/cat/v1/#/). PVRL1 expression is reduced by
a maximum fold change (MFC) of −1.87 with a false discovery rate
(FDR) of 0.0438, whereas PVRL3 expression has a MFC of −1.94 and
FDR of 0.0248 (http://fantom.gsc.riken.jp/cat/v1/#/).
Two additional genes involved in ocular pathologies are located at
the boundary between TAD-1 and brTAD of the 11q23.3 breakpoint
(Fig. 4). The first is the membrane frizzled-related protein gene (MFRP)
whose mutations cause microphthalmia isolated 5 (MCOP5; OMIM
#611040) and nanophthalmos 2 (NNO2; OMIM #609549). The second
gene is the complement-C1q tumor necrosis factor-related protein 5
(C1QTNF5) associated to late-onset autosomal dominant retinal de-
generation (LORD; OMIM #605670).
The 18q11.2 breakpoint was localized at position
g.22,630,751_22.640,752 [hg38] and a 13 bp duplication (TACAGAG
ATGTAC) of the chromosome 11 sequence was identified at the
breakpoint junction (Supplementary Fig. S3). This breakpoint is loca-
lized within the intergenic region of genes involved in tumorigenesis,
namely cutaneous T-cell lymphoma-associated antigen 1(CTAGE1) and
retinoblastoma binding protein 8 (RBBP8) also known as CtBP-inter-
acting protein (CtIP) (Supplementary Figs. S4 and S5). The first is lo-
calized within the brTAD, about 270 kb proximal to the breakpoint and
is associated with cutaneous T-cell lymphoma. Within the same TAD is
localized a member of the small family of zinc finger factors, the GATA6
binding protein 6 (GATA6). This gene is associated with several auto-
somal dominant congenital heart defects (OMIM #614474, #614475,
#187500, #217095 and #600001). However, no heart defect has been
reported in the proposita. Distally, the breakpoint-flanking RBBP8 gene
is situated in the adjacent TAD (TAD+1) at 235 kb, and has been as-
sociated with autosomal recessive Seckel and Jawad (dysmorphic)
syndromes (SCKL2, OMIM #606744; JWDS, OMIM #251255) (Qvist
et al., 2011). On the contrary of RBBP8 neither of the breakpoint
flanking genes (CTAGE1 and GATA6) display significant interactions
across the breakpoint (Supplementary Fig. S5 and S6a-c). Presently,
none of these genes from 18q11.2 are considered as a candidate for this
ocular anomaly (Supplementary Fig. S5).
Computational prediction of Phenomatch score, MaxPhenoScore
and Pheno_percentile, that define the similarity between the proposita's
phenotype and those clinical traits associated with genes from the
breakpoint regions, and position effect prediction scores were calcu-
lated according to a recently reported method (Zepeda-Mendoza et al.,
2017). A significant Pheno_percentile of 0.84 (significant if > 0.75)
and the highest prediction score of 3 (maximum score is 5) was ob-
tained for PVRL1. Presently, OAF is not linked to any phenotype;
therefore, no phenomatch score could be obtained.
Fig. 2. Ideogram of chromosome 11, physical gene map and TADs within the breakpoint region. A) Schematic ideogram of chromosome 11; the breakpoint region is highlighted by a red
box. B) Detailed gene map across the 11q23.3 breakpoint region. Horizontal lines with arrowheads indicate the position of genes in sense (above the map) and antisense (below the map)
orientation. Genes are color-coded according to their haploinsufficiency index (HI) available at https://decipher.sanger.ac.uk/and the HI score is indicated below. Most important
candidate genes are marked with a hash mark (#). Arrows indicate the breakpoint position within OAF. C) Topologically associated domains across the breakpoint. The TADs in human
IMR90 fibroblasts (IMR90) and LCLs GM12878 are shown below [hg38].
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3.4. Mutation screening of CYP1B1 and unbalanced genomic alterations
The proposita was screened for mutations within CYP1B1 and for
genomic imbalances. Neither mutations within CYP1B1, nor genomic
imbalances affecting CYP1B1 or the breakpoint regions, were observed.
The imbalances identified elsewhere in the genome are most likely
CNVs (Supplementary Table S4).
3.5. Expression studies
First, Human Gene 1.0 ST expression array profiling of LCLs of the
proposita revealed two genes, cytochrome P450 family 1 subfamily B
polypeptide 1 (CYP1B1 on 2p22.2) and EGF-like repeats and discoidin
domains 3 (EDIL3 on 5q14), with highly significant altered expression
as compared to controls. Consequently, a 16.5-fold decrease and 126-
fold increase, respectively, was confirmed by TaqMan expression assay
(Table 1 and Fig. S7). The association of CYP1B1 dysfunction with
ocular pathologies, including PA, is well known (Vincent et al., 2006).
Therefore, the CYP1B1 expression level was also analyzed in the per-
ipheral blood of the proposita; the expression level was not significantly
different from the controls (CYP1B1 fold change 2-ΔΔCq= 3.048 ±
0.164 vs. 4.256 ± 0.517). Furthermore, the reduction observed in the
proposita's LCLs was compared with CYP1B1 expression levels from
LCLs with a homozygous as well as a heterozygous 13-nt deletion in
CYP1B1 exon 3 (data not shown). This suggests that the observed re-
duction in expression observed exclusively in the proposita's LCLs is
insufficient to be considered as pathogenic.
The expression level of genes mapping to both breakpoint regions
was also analyzed. Compared to the controls, those from the 11q23.3
brTAD are increased whereas those from the 18q11.2 brTAD are not
notably different (Table 1; Fig. 4 and S5). Subsequently, most of these
genes were also analyzed by TaqMan expression assay (Supplementary
Fig. S8). With exception of the OAF, disrupted by the breakpoint, ex-
pression results were concordant. As expected, the allele-specific OAF
expression assay shows a reduction of the expression level from the
allele disrupted at exons 3-4 junction.
Subsequently, we also carried out RNA CaptureSeq of samples from
peripheral blood and LCLs of the proposita and controls, across the
reference TAD regions. RNA CaptureSeq results are presented as a heat
map of log2 CPMs (counts per million; Supplementary Fig. S9). Ex-
pression profiles between blood and LCL samples were significantly
different.
In addition to the wild-type OAF transcripts, four different chimeric
transcript isoforms have also been identified (Fig. 5). As all chimeric
transcripts utilize the consensus splice donor/acceptor dinucleotide
sequences, they cannot be considered as artifacts. Theoretically, the
chimeric OAF variant consists of a 66 amino acids polypeptide encoded
by OAF exons 2 and 3 followed by an additional pentapeptide encoded
by the chromosome 18 derived sequence. This variant is most likely
degraded.
Hypothetical candidate genes from both breakpoint regions were
then analyzed for their expression during normal murine ocular lens
development at various embryonic stages from E10.5 to E17.5, at post-
natal day P0 and P56, as well as in isolated mouse lens epithelium at
P28. The mouse orthologue of the OAF candidate gene, disrupted in the
proposita by the 11q23.3 breakpoint, exhibits high expression as early
as E10.5, and progressively elevated expression throughout the ana-
lyzed stages. Furthermore, its expression is significantly enriched in the
lens and in isolated mouse lens epithelium at P28 (Fig. 6). Previously,
significant lens-enrichment has led to the identification of several new
genes linked to ocular developmental defects (Agrawal et al., 2015;
Lachke et al., 2012). On the contrary, Pvrl1 is expressed from E10.5 to
E12.5 and is down-regulated at later stages. It is only enriched in the
E11.5 and E12.5 lens as compared to the WB reference dataset. Fur-
thermore, Oaf is expressed and enriched at several-fold higher levels in
mouse lens epithelium as compared to Pvrl1.
Three of the analyzed genes from 11q23.3, namely ARHGEF12,
USP2 and TMEM136, exhibit significantly enriched expression patterns
Fig. 3. Circos plot of interaction profiles of main candidate genes OAF and PVRL1 from the 11q23.3 breakpoint in IMR90 fibroblasts and LCLs GM12878. The blue and dark grey outer
tracks depict TADs in IMR90 and LCLs, respectively. The analyzed gene regions are highlighted by tawny lines whereas the position of translocation breakpoint is indicated by a black
line. Color-coded histograms show the gene expression levels in LCLs, and are depicted in sense (above the map) and antisense (below the map) orientation. In the inner circles,
interaction frequencies between each gene and the reference genomic region are depicted in the blue and black histograms, for the IMR90 and LCL, respectively.
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throughout the analyzed mouse lens stages (Supplementary Fig. S10).
From 18q11.2, only RBBP8 exhibits significant expression without en-
richment in mouse lens between E10.5 through E17.5.
3.6. Breakpoint regions in the context of TADs
The identification of TADs, whose disruption may contribute to the
pathogenic effect of balanced chromosome rearrangements, prompted
us to analyze our data in the context of these genomic interaction do-
mains (Lupiáñez et al., 2015). Total, disrupted and maintained in-
trachromosomal interactions of reference TADs from both breakpoint
regions are presented in Supplementary Table S5.
The 11q23.3 breakpoint region displays a considerable level of
heterogeneity between TAD boundaries in the two analyzed cell lines.
This is associated with the absence of a clear correlation between
boundary regions and CCCTC-binding factor (CTCF) sites (Fig. 4). Al-
though OAF and PVRL1 are located within the same TAD only in the
IMR90 fibroblasts, the interaction profile of PVRL1 observed in LCLs
suggests that the brTAD boundary may well be further distal from the
established TAD boundary (Fig. 4). The CBL and TECTA genes, localized
in adjacent TADs and associated to autosomal dominant conditions, are
not involved in significant interactions across the breakpoint
(Supplementary Fig. S11f and g).
In IMR90 fibroblasts, the 18q11.2 brTAD is the first centromeric
TAD on the long arm. In this region, TAD boundaries are observed to be
relatively constant between cell lines and associated with the presence
of CTCF-binding sites (Supplementary Fig. S5). This implies that the
breakpoint does not substantially affect homeotic chromatin archi-
tecture at the 18q11.2 locus.
Transcribed human enhancers (FANTOM, http://enhancer.binf.ku.
Fig. 4. Heat maps of the 11q23.3 breakpoint region.
A) Hi-C chromatin interaction heat maps for IMR90 fibroblasts and LCL GM12878, respectively. Heat maps were generated from publicly available GEO GSE63525 datasets (https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE63525). TADs and boundaries are indicated by the overlaid blue lines and are in agreement with published data. According to the
interaction profile of this breakpoint region in LCL, the revised breakpoint-spanning topologically associated domain (brTAD) boundary is depicted by the blue dashed line. The black
overlaid lines and arrows indicate the 11q23.3 breakpoint. Gene map across the analyzed genomic region is shown below. Forward and reverse arrowheads indicate the position of genes
in sense or antisense orientation. Genes are color-coded according to their haploinsufficiency index (HI) available at https://decipher.sanger.ac.uk/. All protein coding genes within the
bpTAD are indicated whereas in adjacent TADs only genes proposed to be associated with human disorders are indicated. Genes presently associated with autosomal dominant disorders
are in bold, whereas those associated with autosomal recessive disorders are underlined. Candidate genes are indicated by a hash mark(#).
B) Transcribed human enhancers (http://enhancer.binf.ku.dk/enhancers.php) from the reference genomic regions are shown color coded according to their tissue and cell specific
expression: in dark red ( ) eye tissue with or without retinal pigment epithelial cells; in grey ( ) nervous system; in yellow ( ) immune system; in black ( ) ubiquitous expression. Three
intergenic eye-specific expressed human enhancers have been identified. One is localized within the USP2 and two within the PVRL1. Additional brain specific enhancers have also been
identified proximal to the 11q23.3 breakpoint.
C) Track depicting CCCTC-binding factor (CTCF) sites from the analyzed region according to Chip-seq track in the IMR90 fibroblasts (IMR90 CTCF IgG-rab ChIP-seq Signal from ENCODE/
SYDH; ENCODE Project Consortium).
D) Color-coded bar plot with the average fold change (Log2FC) of indicated genes. White bars depict genes with FC between−0.05 and 0.05. Black bars indicate genes without expression
in LCLs.
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dk/enhancers.php) from the reference genomic regions are summarized
in Fig. 4, and Supplementary Figs. S5 and S12. About 54 kb distal from
the 18q11.2 breakpoint a significantly expressed enhancer in retinal,
lens and iris derived cells was identified. Additional epithelial cell
specific enhancers are also present in this genomic region
(Supplementary Fig. S12).
4. Discussion
We report the balanced chromosome translocation t(11;18)
(q25;q11.2)dn in association with an ocular anomaly characterized by
developmental KLD or type 2 PA (OD), ectopia lentis (OS) and mild CNS
abnormalities. As recently reported by Redin et al. a causal relationship
between a congenital anomaly and an associated balanced chromo-
somal rearrangement is expected to occur in up to 40% of the affected
subjects (Redin et al., 2017).
Exclusion of the pathogenic significance of reduced CYP1B1 ex-
pression observed exclusively in the proposita's LCLs and of genomic
imbalances, reinforced the notion of the proposita's phenotype being
the result of functional impairment of the genes (directly or indirectly)
affected by the translocation. Therefore, comprehensive structural and
functional analyses of the breakpoint regions and adjacent genes were
undertaken.
The only gene disrupted by the breakpoints is OAF, the human or-
thologue of the Drosophila oaf. Homozygosity for transposon-induced
oaf mutations led to lethality at late embryogenesis or at first instar
larva stage. Mutant embryos show nervous system defects suggestive of
its involvement in proper neuronal development (Bergstrom et al.,
1995). Expression studies confirmed the presence of oaf transcripts in
central nervous system (CNS), at stage-15 and 16 (Mukai et al., 2006).
The human OAF is a mature protein of 246 amino acids that shares
38.7% identity and 55.8% similarity with the Drosophila oaf. Reported
FANTOM CAT (http://fantom.gsc.riken.jp/cat/v1/#/) data on OAF
highlight its possible involvement in corneal development. Abnormal
placement of pupils, failure of eyelids to open and abnormal retinal
pigmentation have been reported in Oaf knockout mice (http://www.
mousephenotype.org/data/genes/MGI:94852#section-associations).
Furthermore, high OAF protein level was reported in vitreous humor of
the eye (http://www.genecards.org/cgi-bin/carddisp.pl?gene=OAF).
However, a 69.5-kb deletion encompassing the entire OAF (variant
nsv518464, http://dgv.tcag.ca/dgv/app/variant?id=nsv518464&ref=
NCBI36/hg18) was identified in an apparently disease-free subject. We
propose OAF as a strong candidate contributing to the observed phe-
notype.
Knockout of either cell-adhesion proteins PVRL1 or PVRL3 in the
mouse results in virtually identical microphthalmic ocular phenotypes
(Inagaki et al., 2005). Furthermore, disruption of PVRL3 causes bi-
lateral congenital cataracts and mild developmental delay (Lachke
et al., 2012). Computational prediction of position effect and of phe-
notype similarity (phenomatch) also corroborate the involvement of
PVRL1 in this phenotype. Additional cell adhesion and polarity pro-
teins, such as cadherins, protein kinase C lota (PRKCI) and signal-in-
duced proliferation associated 1 like 3 (SIPA1L3), have been reported to
cause abnormal lens development including bilateral congenital
Table 1
Summary of gene expression data obtained by different methods.
Gene aPredominant expression bMouse lens Assay Proband Desc. Statistics
cLog2 dValue Average SD
11q23.3 region
USP2 Skeletal muscle, testis SignExp&
Enrich
HuGene-1.0 0.73 6.02* 5.34 0.21
CapRNASeq 4.15 5.33* 1.18 2.21
PVRL1 Esophagus mucosa, Skin SignExp&
Enrich
HuGene-1.0 0.98 8.19* 7.28 0.29
CapRNASeq 1.87 12.04* 10.17 0.63
RT-qPCR 0.48 1.04* 0.87 0.53
TRIM29 Esophagus mucosa, Skin Not Sign Exp&Enrich HuGene-1.0 0.59 6.84* 6.19 0.20
CapRNASeq 4.53 7.09* 2.56 1.93
OAF Liver SignExp&
Enrich
HuGene-1.0 0.10 6.99 6.79 0.21
CapRNASeq 0.77 7.34 6.57 0.90
RT-qPCR −0.37 0.12 0.21 0.15
POU2F3 Skin Not analyzed HuGene-1.0 0.28 7.29 7.0 0.40
CapRNASeq 1.62 7.32 5.71 1.43
RT-qPCR 1.55 0.51 0.29 0.34
TMEM136 Brain SignExp&
Enrich
HuGene-1.0 0.44 6.86 6.5 0.37
CapRNASeq 0.04 8.12 8.08 0.72
RT-qPCR 1.84 0.36* 0.18 0.11
ARHGEF12 Brain SignExp&
Enrich
HuGene-1.0 0.30 9.55 9.27 0.26
CapRNASeq 0.00 12.06 12.06 0.35
RT-qPCR 0.69 0.59* 0.37 0.15
18q11.2 region
GATA6 Ovary Not Sign Exp&Enrich HuGene-1.0 0.01 6.67 6.66 0.13
CapRNASeq −0.59 1.26 1.85 1.01
CTAGE1 Testis Not analyzed HuGene-1.0 −0.11 3.73 3.70 0.10
CapRNASeq −3.39 −9.97 −6.57 4.22
RBBP8 Kidney, Testis SignExp HuGene-1.0 −0.05 9.38 9.43 0.27
CapRNASeq −0.18 11.03 11.21 0.35
CYP1B1 Tibial nerve Not analyzed HuGene-1.0 −3.45 6.05* 9.51 0.90
RT-qPCR −3.59 0.08 1.31 1.2
EDIL3 Brain, arteries Not analyzed HuGene-1.0 5.91 9.83 3.88 0.35
RT-qPCR 14.51 0.147** 0.0012 0.004
aAccording to Genotype-Tissue Expression (GTEx) dataset http://www.gtexportal.org/home/and bmouse lens expression datasets (see the Results section and Fig. 6 and Supp. Fig. S10).
Array dada are expressed in log2FCc and normalized expression leveld (NEL); RNA CaptureSeq data is reported as log2FCc (proband vs. Controls) and log2 CPM+0.001d; and TaqMan RT-
qPCR assay in 2ˆ-ΔΔCqc and 2ˆ-ΔCtd. One asterisk indicates difference greater than 1.5 SD whereas two asterisks indicate statistical significance.
Significantly expressed and enriched: SignExp&Enrich; Significantly expressed: SignExp; Not significantly expressed or enriched: Not SignExp&Enrich.
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cataract (Greenlees et al., 2015). Based on the available data we pro-
pose PVRL1, an interacting partner of PVRL3, as a major candidate
gene, whose misregulation most likely contributes to the clinical phe-
notype described above. Therefore, we hypothesize that quantitative
and spatiotemporal deregulation of PVRL1 expression disturbs apex-
apex junctions in target ocular and brain tissues affected by this
anomaly (between anterior lens epithelium and fiber cells as well as of
ciliary epithelia) leading to the KLD, EL and neurologic impairment.
Adoption of RBBP8 enhancers on the der(11) allele may represent the
mechanism contributing to the misregulation of PVRL1 expression
(Supplementary Fig. S12).
The proposita does not present symptoms of conditions linked to
dominantly inherited genes localized within the analyzed TADs from
the breakpoint regions. Even GATA6, which is associated with con-
genital heart defects, has a haploinsufficiency index (HI) of 4.25, and is
localized within the 18q11.2 brTAD, is most likely not involved in the
phenotype (Supplementary Figs. S4 and S5). Corroborating this, non-
pathogenic CNVs (both loss and gain) affecting GATA6 as well asMFRP,
TECTA, PVRL1 have been reported (http://dgv.tcag.ca/gb2/gbrowse/
dgv2_hg19/).
Clinical phenotypes associated with balanced translocations not
leading to haploinsufficiency of a single gene are generally unique
partially overlapping known syndromes. Regarding, the small-sized
eyes with abnormally short axial length presented by the proposita, it
partially overlaps the dysfunction of MFRP, which also causes dereg-
ulation of axial eye length. However, based on the lack of expression in
the developing lens, MFRP is not proposed as a candidate gene.
Furthermore, the ocular phenotype reported here is different from ty-
pical marfanoid eyes that usually are myopic, big and with increased
axial length. Therefore, we conclude that the proposita has an asym-
metric ASD in both eyes leading to KLD (OD) and EL (OS). We do not
have any indication of a mechanical disturbance of the lens-corneal
adhesion.
The extensive bioinformatics analyses of the reference TADs from
each translocation breakpoint, despite highlighting gaps in our current
knowledge regarding chromatin-interacting domains, support our con-
clusions. The analyzed TAD regions are considerably different not only
between human cell lines but also between the two breakpoint regions.
It seems reasonable to hypothesize that TADs with weak boundaries
and excessive CTCF-binding sites throughout the domains, such as in
the 11q23.3 region, are more prone to give rise to new TADs as a result
of a chromosome rearrangement. Hypothetically, depending on the
genomic content of the new TADs, these will be preferentially patho-
genic.
As ocular tissue biopsies from the proposita were unavailable and
data from LCLs may not reflect the spatial and temporal expression of
the candidate genes during development, additional mouse models
were used for developmental expression studies. As lens development
progresses through embryonic, early post-natal and adult stages, Oaf
expression is progressively elevated and is significantly enriched in the
lens. On the other hand, Pvrl1 is expressed, albeit at lower levels, at the
ocular developmental stages relevant to the phenotype. Finally, the
findings that lens epithelium, the tissue component that remains con-
nected to the overlying cornea in type 2 PA, normally exhibits high Oaf
expression and low Pvrl1 expression in contrast to the proposita, who
exhibits low OAF and high PVRL1 expression, add further likelihood
that disruption of OAF and deregulation of PVRL1 contribute to the full
manifestation of the phenotype. This may explain the failure of whole-
exome sequence to identify isolated mutations within these genes in
unrelated patients with PA (Weh et al., 2014).
The altered expression level of genes within the 11q23.3 break-
point-spanning TAD suggests that we cannot exclude that other genes
Fig. 5. Chimeric transcripts identified in LCLs by RNA CaptureSeq.
A)BLAT alignment of chimeric transcripts to the reference genome.
B) Schematic representation of the chimeric transcript isoforms. Coding and intronic sequences are in upper and lower case-letters, respectively. Coding triplets are highlighted in brown
and black. Splice sites are indicated by arrowheads and underlined. The full-length fusion intronic sequence (//) is not shown and the breakpoint within this is depicted by the arrow. C)
Hypothetical translation product of the chimeric transcripts.
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from this region may also contribute to the clinical phenotype, in-
cluding the neurological impairment observed in this subject.
It can be hypothesized that OAF, a protein present in the vitreous
fluid, with high developmental expression during lens morphogenesis,
and recently associated with corneal topography and disease, is re-
quired for normal separation of the cornea and lens tissues; moreover,
elevated expression of PVRL1, coding for a cell-adhesion factor med-
iating apex-apex adhesion junctions in ocular and brain tissues, may
lead to the persistence of the lenti-corneal stalk. Taken together, these
findings suggest a cooperative role for OAF and PVRL1 in ocular de-
velopment.
Research addressing clinically relevant ocular abnormalities asso-
ciated with chromosome rearrangements provides valuable insights
into gene action controlling eye development and, in this case, the
development of the anterior chamber of the eye.
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Fig. 6. Lens-specific expression patterns of the mouse orthologues of the OAF and PVRL1 candidate genes. A) Oaf exhibits high expression (> 100 fluorescent probe binding intensity
units, p < .05) in the developing lens starting from E10.5, when the lens vesicle is in the process of separating from the overlying ectoderm that will form the future cornea. Furthermore,
its expression is progressively elevated through embryonic, early post-natal and adult stages (from E10.5 through P56). Compared to the whole embryonic tissue minus eyes (WB)
reference dataset, Oaf expression is also progressively significantly enriched in the lens. B) Pvrl1 is significantly expressed in mouse lens at E11.5-E12.5 and is down-regulated in later
stages. It is enriched in the E11.5 and E12.5 lens compared to the WB reference dataset. C) Oaf exhibits high absolute microarray fluorescent expression intensities in isolated mouse lens
epithelium at P28. D) Oaf is enriched at several-fold higher levels compared to Pvrl1 in mouse lens epithelium. Error bars represent standard error of the mean (SEM). Red dotted line
represents expression cut-offs at fluorescent probe intensity of 100. This cut-off is based on prior experience of independently validating candidate genes by alternate experiments.
Asterisk (grey) represents significant differences between designated comparisons in lens stages with WB (p < .05). Asterisk (black) represents significant expression in the lens
(p < .05).
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Appendix A. Supplementary data
Supplementary data related to this article can be found at http://dx.
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